Friday, December 17, 2010

ACTC Markets Are Just Starting Appreciate Significance of Their Stem Cell, Derived Treatments Stem Cell Stock

"Stem Cells could and do currently provide enormous benitfit to a great many"....The condition destroys the pigmented layer of retina (retinal pigment epithelium) which is the pigmented cell layer just outside the neurosensory retina that nourishes retinal visual cells. Advanced Cell Technology has shown success introducing the embryonic stem cell derived RPE cells into the eye in animal models and this resulted in 100% improvement with no side effects for more than 220 days. Human clinical trials are expected to start in the first quarter of 2011, and can potentially take only a few weeks to show positive results. ...


No comments:

Post a Comment